Source: Health Canada shortage reports · Updated Jul 28, 2026
A shortage of Propafenone is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
An antiarrhythmic medicine used to treat irregular heart rhythms.
Products affected
0 / 12
Reports on file
46
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Anticipated
MYLAN-PROPAFENONE
300MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457164 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
150MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457172 · ended Feb 13, 2026 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
300MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457164 · ended Feb 13, 2026 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
150MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457172 · ended Jul 3, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
300MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457164 · ended Jul 2, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
150MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457172 · ended Jun 10, 2025 · Disruption of the manufacture of the drug.
Resolved
RYTHMOL
300MG · TABLET · BGP PHARMA ULC
DIN 00603716 · ended Apr 11, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
150MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457172 · ended Mar 13, 2025 · Disruption of the manufacture of the drug.
Avoided
MYLAN-PROPAFENONE
150MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457172 · ended Nov 21, 2024 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
300MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457164 · ended Nov 26, 2024 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
150MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457172 · ended Nov 21, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-PROPAFENONE
150MG · TABLET · APOTEX INC
DIN 02243324 · ended Apr 25, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 46 reports. All reports are on file with Health Canada.
What's happening
A manufacturer has told Health Canada it expects supply of Propafenone to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Propafenone is classified under “ANTIARRHYTHMICS, CLASS I AND III” (ATC C01BC).
Recent changes
Jul 13, 2026
New report filed
Common questions
What is Propafenone used for?
An antiarrhythmic medicine used to treat irregular heart rhythms.
When will Propafenone be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Propafenone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.